@AmyLynnAho talking at 6th Detroit Stroke Conference about Navigating the Post-Stroke Journey, highlighting the Herculean effort and costs required by patients and their care givers in their recovery post stroke. A real hero! @HenryFordNeuro @RiadRmdn
ARAMIS Open label RCT DAPT vs tPA in Chinese minor stroke (NIHSS<6): median NIHSS 2. DAPT non-inferior with lower risk of deterioration and lower bleeding events. Higher NIHSS may be better w tPA. This is big deal #ISC23 @HenryFordNeuro @OwaisAlsrouji @GhadaMohamedMD @aboulnourh
SELECT2 RCT for large core: median ASPECTS 4 and inf core 80cc. NNT for benefit of 4.94. OR 1.51 for benefit. sICH 0.6% vs 1.1%. #ISC23 @HenryFordNeuro @OwaisAlsrouji @GhadaMohamedMD @aboulnourh @WBrinjikji
ANGEL-ASPECT RCT of EVT for large core <24hrs: stop early for EFFICACY! Median ASPECTS 3 & inf vol 60-63cc. Benefit all subgroups. sICH 6.1% vs2.7%. No diff in mortality. Less sleep for us, less disability for pts #ISC23 @HenryFordNeuro @OwaisAlsrouji @GhadaMohamedMD @aboulnourh
CATIS2 RCT early or delayed BP control post AIS (without IVT or EVT) no diff in 90d mRS #ISC23 @HenryFordNeuro @stephanamayer @OwaisAlsrouji @GhadaMohamedMD @aboulnourh
BEST2 RCT of BP after successful EVT: BP<140 better than 160 or 180 reducing infarct volume with no harm and marginal mRS benefit. No diff in sICH. Tighter BP control may be better.
#ISC23 @HenryFordNeuro @stephanamayer @OwaisAlsrouji @aboulnourh @WBrinjikji
LACI-2: open label Isosorbide or cilostazol or combination for lacunar stroke and dependency prevention. The combination appeared to be safe and reduced recurrence and dependency. More data needed @HenryFordNeuro @GhadaMohamedMD @OwaisAlsrouji @aboulnourh #ISC23
TRACE2: IV tPA vs TNK <4.5hrs without EVT. Non-inferiority confirmed without increase sICH. Combined with better LVO recan, supports time window for tPA is running out. #ISC23 @HenryFordNeuro @OwaisAlsrouji @GhadaMohamedMD @aboulnourh
2
263
Is this the first meaningfully + neuroprotectant trial? APRIL showed lower mortality, infarct vol, better outcomes with ApToll infusion+EVT #isc23 @HenryFordNeuro @OwaisAlsrouji @WBrinjikji @stephanamayer @GhadaMohamedMD @aboulnourh
EVT for BA occl highly effective & assoc w (first time ever) reduced mortality in Veritas analysis of 4 RCT. If there is tissue at risk, disabling deficit and LVO then it doesn’t matter the circulation! #getclotout @AHAMeetings @HenryFordNeuro @WBrinjikji
Andreas Charidimou just gave exceptional & informative talk on Dx & mgt. of Cerebral Amyloid Angiopathy- a frustratingly challenging cause of ICH #DetroitStroke2022 @HenryFordNeuro @OwaisAlsrouji @DaiWaiOlson @GhadaMohamedMD
Truly honored to host Ajay Wakhloo as one of our keynote lectures on advances in cerebral aneurysm mgt. for Detroit Stroke Conference 2022. @HenryFordNeuro @SteveKalkanisMD @OwaisAlsrouji @Ammarjumah4
Adieu to one of brightest residents I’ve ever trained @aboulnourh. He’s the future of stroke & neurointerventional. Off to @EmoryUniversity Stroke fellowship where I know he will shine 💪🏻 passion, inquisitiveness and determination. @HenryFordNeuro @GhadaMohamedMD @OwaisAlsrouji
Interesting subanalysis of HERMÈS collaboration. The very old (>85) have more mortality benefit from thrombectomy. #ISC22 @HenryFordNeuro @GhadaMohamedMD @aboulnourh @StrokeAHA_ASA @svinsociety @OwaisAlsrouji
Congrats Hassan Aboul Nour for receiving the 2021 SVIN Trainee Pilot Grant. It’s easy to mentor trainees of this caliber: driven, inquisitive, & scientifically rigorous. I expect this will be only the first of many awards to come. @HenryFordNeuro @aboulnourh
4
32


























